StonvexLoading…
StonvexStonvexStonvexCore line items from CWAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $221.23M | $731.37M | $513.91M | $308.80M |
Operating Income | $8.99M | $-7.69M | $-943.00K | $-7.50M |
Net Income | $-2.78M | $-38.81M | $-26.74M | $-16.55M |
EPS (Diluted) | $-0.01 | $-0.14 | $-0.10 | $-0.07 |
Total Assets | $3.03B | $3.03B | $2.99B | $3.02B |
Total Liabilities | $972.29M | $1.00B | $988.96M | $1.03B |
Cash & Equivalents | $81.51M | $91.25M | $60.75M | $68.40M |
Free Cash Flow OCF − CapEx | $11.23M | $164.34M | $112.05M | $67.13M |
Shares Outstanding | 294.99M | 271.32M | 265.50M | 254.07M |